TGM2 and central nervous system cancer: Sullivan et al. observed that RA metabolism via the ALDH1A3 receptor transcriptionally upregulated tissue transglutaminase in mesenchymal glioma CSCs, an enzyme associated with aggressive tumors and upregulation of CD44+ glioma CSCs[90].